{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:43:45Z","timestamp":1761061425135,"version":"build-2065373602"},"reference-count":25,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2019.029.1"],"award-info":[{"award-number":["2019.029.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The human cytomegalovirus (HCMV) infects fibroblasts via an interaction of its envelope glycoprotein gO with the cellular platelet-derived growth factor receptor alpha (PDGFR\u03b1), and soluble derivatives of this receptor can inhibit viral entry. We aimed to select mutants with resistance against PDGFR\u03b1-Fc and the PDGFR\u03b1-derived peptides GT40 and IK40 to gain insight into the underlying mechanisms and determine the genetic barrier to resistance. An error-prone variant of strain AD169 was propagated in the presence of inhibitors, cell cultures were monitored weekly for signs of increased viral growth, and selected viruses were tested regarding their sensitivity to the inhibitor. Resistant virus was analyzed by DNA sequencing, candidate mutations were transferred into AD169 clone pHB5 by seamless mutagenesis, and reconstituted virus was again tested for loss of sensitivity by dose-response analyses. An S48Y mutation in gO was identified that conferred a three-fold loss of sensitivity against PDGFR\u03b1-Fc, a combination of mutations in gO, gH, gB and gN reduced sensitivity to GT40 by factor 4, and no loss of sensitivity occurred with IK40. The resistance-conferring mutations support the notion that PDGFR\u03b1-Fc and GT40 perturb the interaction of gO with its receptor, but the relatively weak effect indicates a high genetic barrier to resistance.<\/jats:p>","DOI":"10.3390\/v13061094","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T21:16:58Z","timestamp":1623187018000},"page":"1094","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Selection of Human Cytomegalovirus Mutants with Resistance against PDGFR\u03b1-Derived Entry Inhibitors"],"prefix":"10.3390","volume":"13","author":[{"given":"Kerstin","family":"Laib Sampaio","sequence":"first","affiliation":[{"name":"Institute for Virology, Ulm University Medical Center, 89081 Ulm, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Lutz","sequence":"additional","affiliation":[{"name":"Institute for Virology, Ulm University Medical Center, 89081 Ulm, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8669-3017","authenticated-orcid":false,"given":"Rebecca","family":"Engels","sequence":"additional","affiliation":[{"name":"Institute for Virology, Ulm University Medical Center, 89081 Ulm, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"St\u00f6hr","sequence":"additional","affiliation":[{"name":"Institute for Virology, Ulm University Medical Center, 89081 Ulm, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9282-1783","authenticated-orcid":false,"given":"Christian","family":"Sinzger","sequence":"additional","affiliation":[{"name":"Institute for Virology, Ulm University Medical Center, 89081 Ulm, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MOT.0000000000000541","article-title":"Drug-resistant cytomegalovirus: Clinical implications of specific mutations","volume":"23","author":"Razonable","year":"2018","journal-title":"Curr. Opin. Organ Transplant."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/jiv352","article-title":"Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228)","volume":"213","author":"Lischka","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_4","first-page":"127","article-title":"Investigational Antiretroviral Drugs: What is Coming Down the Pipeline","volume":"25","author":"Gulick","year":"2018","journal-title":"Top. Antivir. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.antiviral.2013.03.017","article-title":"Entry inhibitors and their use in the treatment of HIV-1 infection","volume":"98","author":"Haqqani","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2016.04.016","article-title":"Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib\/IIa study","volume":"65","author":"Bogomolov","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wu, Y., Prager, A., Boos, S., Resch, M., Brizic, I., Mach, M., Wildner, S., Scrivano, L., and Adler, B. (2017). Human cytomegalovirus glycoprotein complex gH\/gL\/gO uses PDGFR-\u03b1 as a key for entry. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006281"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nmicrobiol.2016.82","article-title":"Platelet-derived growth factor-\u03b1 receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer","volume":"1","author":"Kabanova","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Stegmann, C., Hochdorfer, D., Lieber, D., Subramanian, N., St\u00f6hr, D., Laib Sampaio, K., and Sinzger, C. (2017). A derivative of platelet-derived growth factor receptor alpha binds to the trimer of human cytomegalovirus and inhibits entry into fibroblasts and endothelial cells. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006273"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.cell.2018.06.028","article-title":"An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor","volume":"174","author":"Marcandalli","year":"2018","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Nguyen, C.C., and Kamil, J.P. (2018). Pathogen at the Gates: Human Cytomegalovirus Entry and Cell Tropism. Viruses, 10.","DOI":"10.20944\/preprints201811.0378.v2"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Feldmann, S., Grimm, I., St\u00f6hr, D., Antonini, C., Lischka, P., Sinzger, C., and Stegmann, C. (2021). Targeted mutagenesis on PDGFR\u03b1-Fc identifies amino acid modifications that allow efficient inhibition of HCMV infection while abolishing PDGF sequestration. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009471"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1128\/JVI.05265-11","article-title":"The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase","volume":"85","author":"Goldner","year":"2011","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8320","DOI":"10.1128\/JVI.73.10.8320-8329.1999","article-title":"Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: A new approach for construction of HCMV mutants","volume":"73","author":"Borst","year":"1999","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-60761-652-8_30","article-title":"En passant mutagenesis: A two step markerless red recombination system","volume":"634","author":"Tischer","year":"2010","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2144\/000114606","article-title":"A TB40\/E-derived human cytomegalovirus genome with an intact US-gene region and a self-excisable BAC cassette for immunological research","volume":"63","author":"Weyell","year":"2017","journal-title":"BioTechniques"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s00705-011-1105-x","article-title":"UL74 of human cytomegalovirus reduces the inhibitory effect of gH-specific and gB-specific antibodies","volume":"156","author":"Jiang","year":"2011","journal-title":"Arch. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0022-2836(67)90307-5","article-title":"Selective extraction of polyoma DNA from infected mouse cell cultures","volume":"26","author":"Hirt","year":"1967","journal-title":"J. Mol. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Park, J., Gill, K.S., Aghajani, A.A., Heredia, J.D., Choi, H., Oberstein, A., and Procko, E. (2020). Engineered receptors for human cytomegalovirus that are orthogonal to normal human biology. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008647"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e00138-19","DOI":"10.1128\/JVI.00138-19","article-title":"The N Terminus of Human Cytomegalovirus Glycoprotein O Is Important for Binding to the Cellular Receptor PDGFR\u03b1","volume":"93","author":"Stegmann","year":"2019","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.cell.2021.01.036","article-title":"Structures of HCMV Trimer reveal the basis for receptor recognition and cell entry","volume":"184","author":"Kschonsak","year":"2021","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E9889","DOI":"10.1073\/pnas.1806305115","article-title":"Role of PDGF receptor-\u03b1 during human cytomegalovirus entry into fibroblasts","volume":"115","author":"Wu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e00332-13","DOI":"10.1128\/mBio.00332-13","article-title":"Human cytomegalovirus (HCMV) glycoprotein gB promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein","volume":"4","author":"Wille","year":"2013","journal-title":"MBio"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wussow, F., Chiuppesi, F., Contreras, H., and Diamond, D.J. (2017). Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells. Vaccines, 5.","DOI":"10.3390\/vaccines5040039"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"eabf3178","DOI":"10.1126\/sciadv.abf3178","article-title":"Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion","volume":"7","author":"Liu","year":"2021","journal-title":"Sci. Adv."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/6\/1094\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:12:14Z","timestamp":1760163134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/6\/1094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["v13061094"],"URL":"https:\/\/doi.org\/10.3390\/v13061094","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2021,6,8]]}}}